| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.003 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.003 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | -0.18 | 0.003 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.17 | 0.003 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.086 | 0.007 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.095 | 0.008 |